Aclarion, Inc. (NASDAQ:ACONW) Short Interest Down 42.8% in July

Aclarion, Inc. (NASDAQ:ACONW) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totaling 2,622 shares, a decrease of 42.8% from the June 30th total of 4,580 shares. Based on an average daily volume of 5,099 shares, the days-to-cover ratio is presently 0.5 days.

Aclarion Price Performance

Aclarion stock remained flat at $0.02 during midday trading on Friday. The company had a trading volume of 18,724 shares, compared to its average volume of 20,739. Aclarion has a 1 year low of $0.02 and a 1 year high of $0.23. The business’s 50 day moving average is $0.03 and its two-hundred day moving average is $0.03.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.